bioRxiv · 10.1101/2020.05.11.089318
Molecular Basis for N-terminal Alpha-Synuclein Acetylation by Human NatB
Abstract
NatB is one of three major N-terminal acetyltransferase (NAT) complexes (NatA-NatC), which co-translationally acetylate the N-termini of eukaryotic proteins. Its substrates account for about 21% of the human proteome, including well known proteins such as actin, tropomyosin, CDK2, and -synuclein (Syn). Human NatB (hNatB) mediated N-terminal acetylation of Syn has been demonstrated to play key roles in Parkinsons disease pathogenesis and as a potential therapeutic target for hepatocellular carcinoma. Here we report the cryo-EM structure of hNatB bound to a CoA-Syn conjugate, together with structure-guided analysis of mutational effects on catalysis. This analysis reveals functionally important differences with human NatA and Candida albicans NatB, resolves key hNatB protein determinants for Syn N-terminal acetylation, and identifies important residues for substrate-specific recognition and acetylation by NatB enzymes. These studies have implications for developing small molecule NatB probes and for understanding the mode of substrate selection by NAT enzymes.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Marmorstein, R., Deng, S., Pan, B., Gottlieb, L., Petersson, J.. 2020-05-13. Molecular Basis for N-terminal Alpha-Synuclein Acetylation by Human NatB. https://doi.org/10.1101/2020.05.11.089318
Cite the original work for its findings. Save a collection to share your selection of sources.